Skip to main content
    K

    Kala Pharmaceuticals Inc (KALA)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $3.56
    +3.42 (+2464.84%)

    Market Cap: $89,480

    Last updated: Nov 17, 2026 at 10:57 AM ET

    Kala Pharmaceuticals Inc (KALA) Competitors

    Updated Nov 17, 2026. Similar companies are ranked by business profile, size, sector and industry; metrics come from company filings and market prices.

    The companies most similar to Kala Pharmaceuticals are Karyopharm Therapeutics (KPTI), Kalaris Therapeutics (KLRS) and Kiora Pharmaceuticals (KPRX). By market cap, Kala Pharmaceuticals ranks 13th of the 13 companies on this page; Nkarta (NKTX) is the largest at $85.23M.

    Peer Comparison

    KALA's revenue growth of -100.0% is below the peer median of 0.0%. Like the median peer, it pays no dividend.

    CompanyMarket capP/EP/SNet marginROICRev growthDiv yield
    Kala Pharmaceuticals (KALA)$89480N/AN/A0.0%N/A-100.0%0.00%
    Karyopharm Therapeutics Inc (KPTI)$394660N/AN/A-153.3%64.5%-11.9%0.00%
    Kalaris Therapeutics, Inc. (KLRS)$37.49MN/AN/A0.0%N/A0.0%0.00%
    Kiora Pharmaceuticals Inc (KPRX)$5.44MN/A6.2x0.0%N/A0.0%0.00%
    Kairos Pharma, Ltd. (KAPA)$1.54MN/AN/A0.0%N/A0.0%0.00%
    CDT Equity Inc. (CDT)$407550N/AN/A0.0%N/A0.0%0.00%
    Mink Therapeutics Inc (INKT)$47.95MN/A236.3x0.0%N/A0.0%0.00%
    Nkarta Inc (NKTX)$85.23MN/AN/A0.0%N/A0.0%0.00%
    OKYO Pharma Limited (OKYO)$70.85MN/AN/A0.0%N/A0.0%0.00%
    Milestone Pharmaceuticals Inc (MIST)$64.74MN/A8.6x0.0%-133.9%-100.0%0.00%
    Telomir Pharmaceuticals, Inc. Common Stock (TELO)$36.15MN/AN/A0.0%N/A0.0%0.00%
    MAIA Biotechnology Inc. (MAIA)$61.75MN/AN/A0.0%N/A0.0%0.00%
    Bioatla Inc (BCAB)$2.89MN/AN/A0.0%N/A31.6%0.00%
    Peer median$36.82MN/A8.6x0.0%-34.7%0.0%0.00%
    Market data as of Nov 17, 2026. Net margin covers the trailing 12 months, Rev growth compares the latest quarter with a year earlier and Div yield is the forward yield. P/E uses earnings per share for the last 12 months as companies report it, often adjusted, so it can show beside a negative net margin, which uses net income. P/E and P/S show N/A when those earnings or sales are negative or missing, or the multiple is above 1,000x.

    Similar Companies

    These are the 12 companies most similar to Kala Pharmaceuticals, ranked by how closely their business, size, sector and industry match. All 12 are in one industry, Biotechnology.

    CompanyAboutPeers
    Karyopharm Therapeutics Inc (KPTI)
    Karyopharm Therapeutics Inc., a pharmaceutical company, is dedicated to the discovery...
    KPTI competitors
    Kalaris Therapeutics, Inc. (KLRS)
    Kalaris Therapeutics, Inc., a clinical-stage ophthalmology biotech company, engages in developing therapies for the treatment of neovascular retinal diseases.
    KLRS competitors
    Kiora Pharmaceuticals Inc (KPRX)
    Kiora Pharmaceuticals Inc. is a clinical-stage biotechnology firm focused on developing innovative therapies for ocular diseases and neurodegenerative...
    KPRX competitors
    Kairos Pharma, Ltd. (KAPA)
    Kairos Pharma, Ltd. is a clinical-stage biopharmaceutical company that develops therapeutics for cancer patients.
    KAPA competitors
    CDT Equity Inc. (CDT)
    Conduit Pharmaceuticals Inc. (CDT) is a clinical-stage biopharmaceutical company focused on creating innovative therapies for oncology and rare diseases...
    CDT competitors
    Mink Therapeutics Inc (INKT)
    MiNK Therapeutics, Inc. is a clinical-stage biopharmaceutical company dedicated to the discovery, development, and commercialization of allogeneic...
    INKT competitors
    Nkarta Inc (NKTX)
    Nkarta, Inc., a clinical-stage biopharmaceutical company, develops and markets cell therapies for the treatment of cancer.
    NKTX competitors
    OKYO Pharma Limited (OKYO)
    OKYO Pharma Limited, a preclinical biopharmaceutical company, is engaged in developing therapies for patients suffering from inflammatory eye diseases and eye...
    Milestone Pharmaceuticals Inc (MIST)
    Milestone Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of cardiovascular drugs.
    MIST competitors
    Telomir Pharmaceuticals, Inc. Common Stock (TELO)
    Telomir Pharmaceuticals, Inc., a pre-clinical-stage pharmaceutical company, focuses on the development and commercialization of therapeutic treatment for human...
    TELO competitors
    MAIA Biotechnology Inc. (MAIA)
    MAIA Biotechnology Inc. is an innovative biotechnology company focused on developing cutting-edge cancer therapies that significantly improve patient outcomes...
    MAIA competitors
    Bioatla Inc (BCAB)
    BioAtla, Inc., a biopharmaceutical company, develops specific and selective antibody-based therapies for the treatment of various cancers.
    BCAB competitors

    Frequently Asked Questions About KALA

    Who are Kala Pharmaceuticals' main competitors?

    The companies most similar to Kala Pharmaceuticals include Karyopharm Therapeutics (KPTI), Kalaris Therapeutics (KLRS), Kiora Pharmaceuticals (KPRX), Kairos Pharma (KAPA) and CDT Equity (CDT), listed from the closest match.

    Who is Kala Pharmaceuticals' biggest competitor?

    Nkarta (NKTX) is the largest of the similar companies at $85.23M; Karyopharm Therapeutics (KPTI) is the closest match by business profile, size, sector and industry.

    How does KALA stock compare with its competitors?

    KALA's net margin is 0.0% against a peer median of 0.0%.

    Which of Kala Pharmaceuticals' competitors pays a higher dividend?

    Kala Pharmaceuticals pays no dividend. None of the similar companies with available yields has a higher forward dividend yield.

    Is Kala Pharmaceuticals bigger than its competitors?

    No. Kala Pharmaceuticals is 13th by market cap among the 13 companies on this page; the largest is Nkarta (NKTX) at $85.23M.